Condition: Obesity · Hypertension · Sponsor: Milton S. Hershey Medical Center
Obesity is a global health concern that is associated with high blood pressure and an increased risk for developing cardiovascular disease. The purpose of this study is to find out if the investigational drug angiotensin-(1-7) can improve cardiovascular health in people with obesity and high blood pressure.
This description comes directly from the study's public registry record.
Aimee Cauffman, RN · 717-531-1617 · acauffman@pennstatehealth.psu.edu
Amy Arnold, PhD · 717-531-3674 · aarnold5@pennstatehealth.psu.edu
Always discuss trial participation with your own doctor first.
| Penn State Milton S. Hershey Medical Center | Hershey, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06482853